CEMI Stock Summary

• With a year-over-year growth in debt of 5,984.09%, Chembio Diagnostics Inc's debt growth rate surpasses 99% of about US stocks.
• Over the past twelve months, CEMI has reported earnings growth of 95.24%, putting it ahead of 89.02% of US stocks in our set.
• Chembio Diagnostics Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -48.17%, greater than the shareholder yield of just 6.67% of stocks in our set.
• Stocks that are quantitatively similar to CEMI, based on their financial statements, market capitalization, and price volatility, are EMKR, AMRS, KOPN, EXTR, and SRTS.
• Visit CEMI's SEC page to see the company's official filings. To visit the company's web site, go to chembio.com.